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A phenomenological analysis 
of the experience of taking 
medication to prevent a further 
heart attack
Hannah Piekarz *, Catherine Langran  & Parastou Donyai 
Following an acute myocardial infarction, patients are prescribed a regime of cardio-protective 
medication to prevent recurrent cardiovascular events and mortality. Adherence to medication 
is poor in this patient group, and not fully understood. Current interventions have made limited 
improvements but are based upon presumed principles. To describe the phenomenon of medicine-
taking for an individual taking medication for secondary prevention for an AMI, Interpretative 
Phenomenological Analysis was used to analyse transcripts of semi-structured interviews with 
participants. Themes were generated for each participant, then summarized across participants. Five 
key themes were produced; the participants needed to compare themselves to others, showed that 
knowledge of their medicines was important to them, discussed how the future was an unknown 
entity for them, had assimilated their medicines into their lives, and expressed how an upset to their 
routine reduced their ability to take medication. Participants described complex factors and personal 
adaptations to taking their medication. This suggests that a patient-centred approach is appropriate 
for adherence work, and these themes could inform clinical practice to better support patients in their 
medicine adherence.
Cardiovascular disease currently causes over 4 million deaths annually in  Europe1. Acute myocardial infarction 
(AMI) is responsible for the largest proportion of these, estimated to be 15% of the  total2. In the UK, just under 
one million people are thought to be AMI  survivors3.
Following an AMI, a combination of five different classes of medicines are recommended as part of treatment 
guidelines for secondary prevention in the  UK4, the  US5, and  Europe6. A meta-analysis of these drug groups has 
found that following the five-drug therapy confers a 40% reduction in mortality and 25% reduction in cardiovas-
cular  events7. Whilst a broader study in coronary heart disease patients, it found that the reduction in all-cause 
mortality and cardiovascular events was due to an additive effect. This highlights the importance of taking these 
drugs in accordance with the prescription issued by a health professional.
Medicine adherence is defined as “the extent to which a patient’s behaviour matches agreed recommendations 
from the prescriber”8. Meta-analytic data from 376,162 patients has shown the level of adherence in patients 
taking medicines for secondary prevention of AMI to be 66%9. This study found no other statistically significant 
differences between the drug classes, which suggests that non-adherence is not related to a drug class characteris-
tic, such as a drug side-effect, but to other factors. Because non-adherence in AMI increases one-year mortality, 
hospitalisations and  costs10, it follows that improving medicine adherence should then reduce patient mortality, 
morbidity and healthcare system costs.
Improving medicine adherence has been a focus for the World Health Organisation (WHO)11, which famously 
reported that “increasing the effectiveness of adherence interventions may have a far greater impact on the health 
of the population than any improvement in specific medical treatments”.
In the UK, the standards of practice for the NHS are determined by the National Institute for Health and Care 
Excellence (NICE), which has produced treatment guidelines for improving medicine  adherence12. This report 
acknowledges the need to understand patient perceptions of their medicine along with the physical practical 
support that can be given to aid patient adherence. It recommends that adherence is supported through patient 
involvement in decision-making, offering information, and being aware of patient concerns.
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There has been much research into finding effective interventions, yet many are complicated and eventu-
ally unsuccessful in terms of improving medicine adherence and clinical  outcomes13. Most adherence research 
uses quantitative methods to determine adherence as an outcome, with a thin evidence base underpinning the 
theoretical framework. A study of the data from adherence studies concluded that most interventions are not 
produced as a result of theoretical  models14, even though interventions aimed at changing behaviour have been 
shown to be more effective when based upon theoretical  models15. Therefore, a qualitative approach would be 
useful to generate themes and propose models which could ratify conceptual frameworks and direct further work 
in quantitative studies. Historically, there is a lack of qualitative research into medicine  adherence16.
Consistent with a patient-centred approach, a qualitative phenomenological study is appropriate to obtain a 
patient perspective of the experience of taking medicines, beliefs, and how patients conceptualise their medicines 
within their  lives17. In addition, a study that includes an exploration of the social context and lived world of a 
patient would be appropriate, and an ethnographic patient interview is suited to this  purpose18.
Interpretative phenomenological analysis (IPA) was chosen as an established accessible methodological 
framework upon which to base this  study19. There is debate between the leading practitioners in phenomenol-
ogy as to the philosophical underpinnings of their own respective  methods20. In order to develop a deeper 
phenomenological aspect to this study, the additional framework of existential life-world categories of time, 
location, embodiment and relationships were used in the  analysis21.
Aim of the study. To describe the experience of an individual taking medication to prevent a further AMI, 
and factors that influence their medicine-taking ability.
Ethics approval. This study was approved by the University of Reading Ethics Committee (Reference 
UREC18/36).
Method
This study followed COREQ guidelines to conduct the  research22. A sample size of four participants was chosen 
to enable a quality analysis to take place, to ensure thoroughness, depth and maintain ideography of the analysis, 
consistent with an Interpretative Phenomenological Analysis (IPA)  study23.
Participants were recruited using a promotional poster cascaded by email within the University of Reading, 
which was also sent to targeted cardiac support groups within the locality of the South-East region of the UK. 
The criteria for inclusion were adult individuals with a diagnosis of AMI and who had been prescribed medica-
tion for secondary prevention of AMI.
Initial contact was made through email with the first author, HP, the study information was distributed, and 
written consent returned in person or via email. Prior to interview, participants were assigned a pseudonym. All 
participants who made initial contact followed through to full interview.
All interviews were conducted by HP in a private office room, either face to face or over the telephone, 
between June 2019 and January 2020. The interviews ranged in duration from 17 to 65 min, and average time 
of 48 min.
A semi-structured interview schedule was used to guide the interviews. The schedule was informed by one 
used in a similar medicine adherence phenomenological  study24, and more general literature on developing 
interview  protocol25. Following the first interview, the schedule was refined in accordance with a self-reflective 
‘interview the interviewer’  technique26, the final schedule can be found in Additional Information. All listed 
questions were put to the participants, and during the interview, further lines of questioning and probes were 
added in response to answers given by the participant as the interview progressed.
Field notes were taken by HP during the interviews as an aid to topic coverage. Immediately following the 
interview, notes were made on meaning of discussion topics, to aid in the analysis. The notebook was used dur-
ing the transcription and analysis stages also, to add a reflexive commentary on the researcher’s thoughts and 
sense-making process.
Interviews were audio-recorded to MP3 file, which was transcribed verbatim by HP into an MS Word text 
document. The transcripts were checked alongside the audio to confirm accuracy. In line with a transparent study, 
participants were sent a copy of their transcript. No participants disagreed with the content of their transcript.
Analysis was undertaken according to  IPA23. All transcripts were analysed by HP, a novice qualitative 
researcher, PhD student and practicing pharmacist. The transcripts were read a minimum of twice, and line-by-
line notes made using an IPA stance, a description of the meaning and understanding by the researcher of the 
participant’s statements. The first transcript notes were discussed with PD, an experienced qualitative researcher 
and Professor of pharmacy practice, with specialisms in anthropology and psychology. This discussion gener-
ated further notes, consistent with a “mini-independent audit”23, a check of validity. This discussion of notes 
was repeated for the second transcript.
Life-world framework categories of time, location, embodiment and relationships were used as an initial 
means of organising and arranging the  notes21. The transcript notes were colour-highlighted by life-world cat-
egory and grouped.
Following the first sift into lifeworld groups, the transcript notes were coded into thematic groups, collected 
together according to concept. These groups were used to write a participant summary document in prose, which 
described each individual, arranged by life-world category. In line with IPA, preservation of the participant’s 
voice is important, and so the original interview quotes were used to illustrate themes. Analysis was repeated 
for each transcript and a summary document was produced for each participant.
The summaries of themes for each participant were grouped together, using overarching themes that encom-
passed all the concepts encoded in the themes that they described. These were the superordinate themes that 
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featured across all the participants’ transcripts. These superordinate themes were organised into tables illustrated 
with the original text quotes from each participant which are presented in the results section below.
Results
The participants (n = 4, 2 women, 2 men) were assigned the pseudonyms Gaye (Table 1), Beki (Table 2), Chris 
(Table 3), and Colin (Table 4). They all described their AMI as a “heart attack” and so this term is used henceforth. 
All participants lived in the South-East region of the UK and came from higher professional or business-owner 
backgrounds in their working career. They all initially received emergency care through the NHS and continued 
their access to healthcare through their NHS general practitioner service. Beki and Chris sought additional care 
through using private consultant cardiologists.
Gaye is a retired woman, in the age range 60–70 years. She had two heart attacks and considers that her healthy 
vegetarian lifestyle is the reason that she survived them. She had difficulty swallowing tablets but overcame this 
by taking her medicines simultaneously with swallowing a grape.
Beki is a working woman in the age range 30–40 years. She had two heart attacks but considers herself an 
anomaly due to her fitness and young age. Her initial diagnosis was not of a heart attack, it was through her own 
research that she found a consultant to confirm a diagnosis of heart attack.
Chris is a retired man in the age range 60–70 years. He had one heart attack. He decants all his medication 
into a Tupperware box in order to save time and hassle. He also takes medication for back pain and restless leg 
syndrome, for which he adjusts doses according to the severity of his symptoms.
Colin is a retired man in the age range 60–70 years. He had one heart attack, whilst on the golf course and 
was air-lifted to hospital away from home. Dissatisfied with the quality of transfer of his care between hospital 
and GP, he sought private healthcare.
The participants discussed medicine-taking through four superordinate themes (Table 5); they compared 
themselves to others, knowledge was important to them, they considered the future in some form, and they 
discussed ways that they fitted their medicines into their lifestyle. A related theme to lifestyle, all participants 
discussed how a change to their routine adversely affected their medicine-taking.
Comparison to others. One of the superordinate themes was the way in which participants focussed on 
their history and lifestyle leading up to their heart attack in reference to other people, often evidencing that they 
were in a superior position, and as proof that their body was healthier by managing to survive the heart attack.
Table 1.  Summarised themes and example interview quotes from Gaye.




Never taken medication 65
…Because I was living that lifestyle (Re: 
survival) 152
As fit as a butcher’s dog 169
Unusual case
Didn’t fit the bill for anyone having a heart 
attack 43
Didn’t fit anyone’s profile 48
Knowledge
Medicine information [Medicine names, dosage and times] 77, 79
Question cause Why had it happened, 146
Question medicines
Are they doing what they’re supposed to? 219
What would happen if I didn’t take them? 220
How does the combination work? 234
Self-perception (medicines) Am I on the highest? Am I on the lowest? 224
Self-perception (fitness) No idea of what level you’re at 176
Sharing knowledge I told her what I’d been told 187
Strength in numbers Collective support (re: rehab group) 234
Considering the future
Planning into the future To be seen in a couple of years 172
Indefinite Continue to have to take these 241
Continuous future Forever and being compliant 242
Unknown future Not knowing where I was heading… 152
Assimilation into lifestyle
Overwhelmed initially Started off with a whole raft of things 52
Physical issue Could never swallow medicines 92
Overcome issue Always have to have grapes 113
Taking medicine is unremarkable It’s just a routine now 107
Disturbance to routine
Being away from home Can be a bit difficult when you’re travelling 113
Distracted by activity Been a particularly busy day, it’s not until the evening when I thought, ‘Crickey!’ 109
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Table 2.  Summarised themes and example interview quotes from Beki.
Superordinate theme Theme Quote Transcript line reference
Comparison to others
Health conscious
Training for the marathon 5
Planning on starting a family 137
Never smoked 259
Been this weight since…a teenager 558
Unusual case
I’m not kind of, your normal case 628
The youngest person on the cardiac 
ward 607
I’m not your fat sixty or seventy 
year-old man 95
My heart function is normal 456
My heart has no damage to it 458
Dislike of labelling I hate that term (re: saying I have heart disease) 448
Knowledge
Medicines information [Medicine names, dosages, timings] 77, 78,79, 159, 190, 192, 222, 246, 248
Self-perception (medical)
Cholesterol…high for me 256
All of the data 116
Seeking information
Load of Googling 422
A bit of PubMed searching 656
A UK Facebook group 427
A lot of my friends are Doctors 696
Spoke to a friend… endocrinologist 657
Sister-in-law is a consultant 734
Cynical of care
They were generally a bit rubbish 99
The ECG technician will answer your 
question 105
Here’s a bag of stuff 293
A whole leaflet of aftercare 296
The woman that hands me… prob-
ably has no clue 976,977
Considering the future
Future unknown Try not to dwell, may happen again 461,462
Continuous future Every day for the rest of my life (re: taking medicine) 344
Planning ahead
Lipids done every year 964
Making an appointment 622
Four medicines every six weeks 648
Assimilation into lifestyle
Consistent location
They’re all in the kitchen 477
Down in the kitchen 375
Reason for location
Out of the way 478
Aspirin has to go in water 374
Child is priority
Had stopped taking the (contracep-
tive) pill 156
Came off statin, clopidogrel 177
Breastfed him 186
A break while I was pregnant 971
Concern for partner’s anxiety
Look like a battered wife (re: bruising 
as side effect) 902
My poor husband… 141
woke up, thought I was dead (re: cold-
ness as side effect) 142
I think my husband worries about it 
more than I do 442
Side effect tolerated For the sake of a year, it’s fine (re: clopidogrel causing bruising) 921
Side effect unacceptable Felt like wading through treacle 138
Disturbance to routine
Being away from home I think probably I was out and thought, ‘oh yeah’ 492, 494
Distracted by activity Just didn’t ’cause I came home and went straight up to bed 495
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Superordinate theme Theme Quote Transcript line reference
Comparison to others
Parallel self
That was the heart attack that would have been fatal 52
And er, if we hadn’t gone – who knows? 85
Thinking—I’ve got cancer 523
Comparison to an acquaintance You know, just passed away on the spot 66
Comparison to relatives
I have two brothers. Both younger 942
He had a triple 944
He needed a bypass, but because of his head (re: other brother has 
pacemaker) 949
We do compare notes between us 968
Unusual case
My heart was undamaged 926
My heart had found ways of getting supplies from other channels 924
It was a re-plumbing job—it wasn’t a heart repair job, which I 
think was quite significant 936, 937, 938
Knowledge
Medicines information [Names, doses, times and identification of medicines] 169, 182, 183, 194, 195, 196, 223,273, 284,285, 286,474
Theoretical knowledge
And also one used for epileptics 180
Which is again, a drug normally used for Parkinson’s disease 190
Practical knowledge
Intelligently, I have, you know (re: self-adjusts dose) 558
Self-diagnosed, self-prescribed 500
Did off my own back 563
Follows advice of professionals
I’ll stick with that one 581
Wouldn’t stop taking that one without taking advice 582
‘Cause it helps with the heart rate 579
If that’s what they say, 976
I won’t question 979
Self-perception (Medicine) I’m on about as low as you can get 575
Self-perception (Medical) My readings seem to come out OK 218
Assimilation into lifestyle
Continuing as usual
And I’m taking it when it fits in with my life 205
Just throw in the morning ‘cos it’s more convenient to me 217
Take them when it fits me 227
Adapting to change in routine
And I get on with it ‘cos it’s only short-term (re: antibiotic course) 340
I’d probably do one of those for the flight time (re: small pill box) 357
It lived in the car all day…Wanted to make sure I had the after-
noon ropinirole with me 368,370
Taking medicines is unremarkable
Sort of, pick them up, chuck them in and swallow them 297
And taken without thinking 113
It’s whatever’s in front of me 292
Like having a cup of coffee or a glass of wine (analogy: routine) 535
Coffee for that, wine for this (analogy: cultural) 1092
Location of medicine
This square box with a green lid that’s got everything in 361
Sometimes it’s in the kitchen 364
Sometimes the worktop, sometimes the cupboard 365
Constructed relationship with regu-
lar medicines
My normal, you know, cocktail 343
A routine, daily medicines, wall to wall 1023
Doesn’t become a part of the family of the rest in my box (re: 
antibiotics) 336,337
It’s a bit of an intruder 339
Made own system
Works absolutely brilliantly 361
That’s my method 389
Sorry, but that’s the way I do it 391
Concern for efficiency
A tenth of the time it would the other way (re: decanting medi-
cine) 433
It’s very timesaving 434
An absolute disgrace (re: overpackaging) 415
Unconcern with adhering to doses
Wouldn’t have bothered me 500
None are things that are life threatening if I miss a day or take 
too many 464
Totally relaxed 467
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This theme was interpreted as participants constructed a ‘typical’ heart attack patient profile for comparison 
in terms of healthy living status, gender, age and type of heart attack. For example, terms like “Didn’t fit the bill 
for anyone having a heart attack”, and “I’m not your fat sixty or seventy year-old man”.
They frequently gave examples of how they were health conscious. They considered that vegetarianism, non-
smoking, training for a marathon, preparing for pregnancy, and gym attendance to be attributes that made their 
health superior. They used their own biometric results to compare their health to normal ranges as justification 
that their health is comparable to ‘normal’. They also described similar diagnoses in acquaintances, friends and 
relatives to discuss how their case was different, with the implication that their case was less morbid. Colin 
defined himself in terms of luck.
Knowledge. The superordinate theme of knowledge encompassed a range of themes that included ques-
tioning the cause of their heart attack and need of their medicines, seeking information, having a theoretical 
and practical knowledge of their medicines, sharing information with others and receiving support as part of a 
group. The category of knowledge also encompassed self-perception, including participants’ understanding of 
their own medical status, fitness, and medication. The concept of having knowledge was interpreted as an under-
standing of their body helped participants to regain control over it. Participants commented they “Read the 
leaflet about what they do and what the side effects are” and asked, “Are they doing what they’re supposed to?”.
All participants were able to describe their medicines and medical treatments. In addition, they showed 
curiosity to know about their treatment, either finding answers themselves or using the knowledge of others. 
Gaye articulated her lack of knowledge about her medicines.
All the participants could recall the names, timings and strengths of their medicines, often referring to paper 
copies of medical notes during their interview, although these were not requested by the researcher. They found 
information through hospital consultants, GPs, acquaintances, family, support group and rehab group members. 
They used sources such as medicine information leaflets and academic-level databases. Two participants sought 
the knowledge of a private consultant, reasoning that the consultants’ professional status conferred a better level 
of care. One participant linked private healthcare with receiving better care and economic status.
Considering the future. This superordinate theme was drawn out by participants as they invoked the idea 
of the future in all their narratives. This theme was interpreted as constructing certainty and reassurance. The 
uncertainty of the future illustrated by “not knowing where I was heading”. Gaye, Beki and Colin all mentioned 
taking medicines continuously into the future, using an almost identical phraseology of “having to take these 
forever”, and Beki’s “every day for the rest of my life”.
Gaye mentioned that the future is unknown in terms of heart health, and Beki considered that another heart 
attack is possible. Colin used the future conditional tense as he talked about having taken his medicine for such 
a long time “it had built up inside”, and that if he missed a dose, it “shouldn’t be a problem”.
Assimilation into lifestyle. Another broad superordinate theme was assimilation of medication into the 
participants’ lives. All participants relayed how they accommodate their medicines into their everyday routine in 
a unique way. This group included themes of personal relationships, medicine location, systems and adaptations. 
This theme was interpreted as fitting medicine-taking to their life-world, a means of control and stability. They 
used phrases such as “Take them when it fits me”, and “It’s just a routine now”.
Gaye and Colin discussed being overwhelmed initially, but then how taking medication has become part 
of their everyday life. They both described the routine they had created, now as unremarkable and not notice-
able. Both Beki and Chris mentioned a difficulty, Beki because of the side-effect, and Chris because of the extra 
quantity to remember, but they persisted with their set treatment.
Gaye began with swallowing difficulties but was given a “tip” by a pharmacist, and now takes medications 
simultaneously with a grape.
The location of medication was discussed as a practical decision or based upon their beliefs. Beki sites her 
medication in her kitchen, “out of the way” as her son’s safety is a priority. Chris decants all packaging and keeps 
them mixed in a Tupperware box, as an efficiency measure. Colin keeps his medication in a pouch which remains 
in one location at home, his GTN spray is the only item that he will carry in his pocket whilst at the gym.
Beki discussed how her pregnancy took priority over her medicine taking, as she stopped taking some of 
her medicines.
Chris and Colin talked about medicine-taking as an effortless activity, both using the analogy of coffee and 
tea-drinking to describe the automatic nature of taking medicines. Chris compared cultural drinking to taking 
different medicines, “coffee for that, wine for this”.
Neither Chris and Colin were concerned about missing doses, Chris reasoning that missing medicines wasn’t 
life-threatening, and Colin because he doesn’t notice any difference.
Superordinate theme Theme Quote Transcript line reference
Disturbance to routine Distracted by activity
Something distracted me and I was doing something unusual late 
last night, 483
I went to bed and forgot that I’d not taken my pills 497
Table 3.  Summarised themes and example interview quotes from Chris.
7
Vol.:(0123456789)
Scientific Reports |        (2021) 11:23468  | https://doi.org/10.1038/s41598-021-02909-5
www.nature.com/scientificreports/
Table 4.  Summarised themes and example interview quotes from Colin.
Superordinate theme Theme Quote Line reference
Comparison to others Chance affects health
I was pretty unlucky to have a clot 469
I’m just so lucky really 729
Knowledge
Medicine information [Medicine names, doses, timing] 26, 28, 29, 30, 31, 32
Seeking superior healthcare
That’s when we decided to see the consultant 
privately 181
For longer than most people would recom-
mend 76, 77
Said ‘stay on the clopidogrel for a further 
year’ 97
Even though the reports say that its rubbish 218
He reckons that it’s worthwhile 219
This consultant, who I trust, said take them 390
He’s pretty well-regarded in his profession 653
Seeking information Read the leaflet about what they do and what the side effects are 629
Self-perception (medical)
Always was fine and always is fine 147
Stable ever since 161
Been settled for quite a long time 202
Not in the last, probably nine years 505
Been taking them for such a long time 338
Drug has built up inside me 340
Self-perception (fitness)
I managed a good peak time 64
A very good walking time 153
Financial exchange to access healthcare
The National Health wouldn’t provide them 83
BUPA don’t think it’s entirely necessary 137
Certainly our GP, they won’t pay for that. 
That’s up to me 138
Surgery stopped paying for Omacor, it was 
do it yourself, if you want it 141
I can afford it, let’s put it that way 452
Considering the future Continuous future I just have to take these forever 169
Assimilation into lifestyle
Initial difficulty
It was all so new then 22
They just said you’re on these, and go 178
Wasn’t in the best for a couple of days 136
A bit difficult to know what each one was 
doing 37
Felt disappointed that I was going to take 
medication 172
Taking medicine is unremarkable
Just as routine as having a cup of tea 379
Just take them and get on and do things 391
It takes 30 s, what’s the problem? 404
Unconcern with missed doses
I don’t notice that I’ve taken anything 209
I don’t get worried if I don’t take them 366
I don’t notice on a daily basis 497
I miss one then never notice any difference 501
Location of medicines
In a little pouch, there the whole time 293,294
Leave them out, just to remind me 290
Take upstairs, to be by my case 607,608
Take out the next morning’s medication 610
The evening medication, and put cling film 
over that 612
Will always have that in my pocket (re: GTN 
spray) 973




When all the family were here 312
The routine is a bit different (re: holiday) 591
Change of timings
Timing dosages to that of the place we are 
going (re: time zone change) 327
Might be wider or less 329
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Disturbance to routine. All the participants discussed how a disturbance to their daily routine could result 
in their missing a dose of medication. Disturbances included being away from home, being on holiday, and 
distraction by another activity. In opposition to the previous theme, this was interpreted as a destabilisation of 
their habitual activity. They described “The routine is a bit different” and saying, “I went to bed and forgot that 
I’d not taken my pills”.
Table 5.  Summary of themes as mentioned by participant.
Superordinate theme Subtheme
Mentioned by participant
Gaye Beki Chris Colin
Comparison to others
Health conscious • •
Unusual case • • •
Parallel self •
Compare to acquaintance •
Compare to relatives •
Chance affects health •
Dislike of being labelled with diagnosis •
Knowledge
Medicines information • • • •
Question cause • •
Question medicines • • •
Self-perception (medicines) • •
Self-perception (fitness) • •
Self-perception (medical) • •
Cynical of care •
Overcome medicine issue • •
Seeking information • •
Theoretical knowledge • •
Practical knowledge •
Follows professional advice • •
Seeking superior healthcare •
Paying for healthcare •
Sharing knowledge •
Strength in number •
Considering the future
Planning ahead • •
Indefinite •
Continuous future •
Unknown future • •
Assimilation into lifestyle
Initial overwhelmed • •
Concern for timing •
Continue as usual • •
Adapting to incorporate change • •
Taking medicine is unremarkable • • •
Unconcerned with adherence • •
Child is priority •
Concern for partner’s anxiety •
Made own system •
Concern for efficiency •
Constructed relationship with regular medicines •
Physical issue •
Side effect tolerated •
Side effect unacceptable •
Location of medicine • • •
Disturbance to routine
Being out of the home • • • •
Being on holiday •
Distracted by activity • • •
Changing of timings •
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Being away from home was discussed as a reason by all participants. Gaye talked about going out and forget-
ting her evening dose of statin. Beki suggested that she might be out and forget to take a dose. Chris took his 
medicine box out with him to ensure he did not miss doses.
Colin’s wife gave him verbal reminders when away on holiday and he mentioned different time zones caus-
ing confusion.
Chris gave the example of being absorbed on the internet and so went to bed without taking the evening dose. 
Colin discussed missing doses when his family came to stay at his home.
Discussion
This study has produced themes that add to our understanding of the experience of medicine taking following a 
myocardial infarction. The participants discussed medicine taking through four superordinate themes. Firstly, 
they compared themselves to others, often using this comparison to bolster their sense of wellbeing and provide 
optimism about themselves. Secondly, knowledge was important to them, to help them construct an understand-
ing of their condition and its management. Thirdly, the participants all considered the future in some form, 
thinking of it as either a constant or an unknown concept. Fourthly, participants discussed ways that they fitted 
their medicines into their lifestyle each making unique adaptations to manage their individual medicines. A related 
theme to lifestyle, all participants discussed how a change to their routine adversely affected their medicine tak-
ing. The study offers an interpretivist perspective in an area weighted towards quantitative research. The themes 
provide patients’ perspectives on medication, extending beyond the simple representation of adherence as either 
intentional or unintentional, helping therefore to give context to people’s engagement with medication following 
a myocardial infarction. These themes could help guide practitioners to provide more patient-centred care in 
future health consultations. They also show that patients adapt medicine taking into their lives in various and 
unique ways and a tailored approach to support them would be appropriate.
Currently medicine adherence support is provided to this patient group at the primary healthcare level 
through GP services, where the main aim is to integrate hospital discharge and return to independent home 
living through a programme of cardiac rehabilitation. While social support and cardiac rehabilitation have been 
well documented to improve treatment outcomes and quality of life measures, it is also apparent that recovery 
is a complicated and multifactorial phenomenon. An important positioning paper by the European Association 
of Cardiovascular Prevention and Rehabilitation highlights the complex role that psychosocial-related factors 
play in both the genesis and recovery of  CHD27. For example, psychosocial factors such as stress, anxiety and 
depression are implicated in the development of CHD, can be caused by CHD, and even reduced by CHD—the 
latter occurring when family rally round to increase social support following a diagnosis. The paper also discusses 
the complex ways that psychosocial factors influence cardiac outcomes and recovery, and how these factors can 
overlap and work in multiple directions, for example acting as barriers to lifestyle changes and treatment adher-
ence. This complexity is in line with the themes untangled in this analysis, some of which conceptually overlap 
and affect one another, further emphasising the need for a patient-centred approach.
The theme of comparison to others and seeing one’s own health protective behaviours as superior to others, 
could be construed as participants’ way of evidencing their own health, maintaining control, and/or providing 
self-reassurance. This theme of comparison to others was also discussed in a narrative analysis of patients taking 
anticoagulant medicines to prevent  stroke28. In that study, participants also constructed themselves as superior 
to others, evidencing their good intentions for example as good adherers while non-adherers were ‘wasteful’ or 
‘ungrateful’. Although a study of a different patient group, it agrees with this study that participants were keen to 
portray themselves as being healthy, adhering to medicines and positive lifestyle measures, and seeing others as 
having less favourable circumstances in terms of health. They found that missing doses was described as due to 
external circumstances of timing and location, and not linked to a personal trait. This supports the notion that 
participants are constructing an identity of positive health and higher morals than others to find comfort and 
gain control away from the tension of the uncertain. This finding highlights the need to consider the individual 
within group activities such as cardiac rehabilitation and social support groups, or when discussing benefits of 
treatment in terms of ‘most patients’.
In the current study, the theme of knowledge is important because of its role in creating coherence whereby a 
clear model of treatment helps participants remove uncertainty and regain control of their self over their illness. 
Another study of the meaning of medication to patients also explored the role that knowledge and meaning 
play in helping patients understand and manage their  medication29. That study found the medication experience 
to be a meaningful encounter, with positive or negative bodily effects, and an unremitting nature which could 
cause patients to question the need for it. The patients could even exert control over the medication through the 
expertise gained from taking it (e.g., take the medication only ‘when required’). Parallels can be drawn with the 
current study under the themes of both knowledge and assimilation into lifestyle, as participants described their 
own experience of medication effects and side effects, sometimes questioning the need to take medication, and 
importantly, gaining control over the medication by simply taking it and not feeling it was unwarranted. This 
emphasis on meaning-making could be thought of as a learning process and therefore prompt practitioners to 
think about where a patient is in their learning journey when delivering patient-centred care.
Similarly, the theme of thinking about the future could add to a sense of coherence and continuity. It is note-
worthy that medicines adherence is not often framed in relation to the concept of the future. In pharmacy, the 
professional focus is traditionally upon medical history and the future extends only as far as the patient’s current 
valid prescription. The use of electronic transfer of record keeping, sharing, prescribing, and repeat batches of 
prescriptions, however, is potentially of benefit in terms of framing the future. This suggests more work could be 
done to investigate the impact of the current model of monthly prescriptions on patients’ sense of their future 
and in turn their medication adherence.
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Medicine-taking exists within the constructed life-world of the patient, affects and is affected by it. The theme 
of fitting into lifestyle, drawn out in this study, highlights the interconnectedness of medicines and patients’ 
life-world. In this study patients had incorporated their medicines into their lives in unique and specific ways 
that were important to them and their beliefs. This adds further weight to the argument that reducing medicine-
taking to ‘cause and effect’ is over-simplistic and of limited practical use. Against the good adherence work that 
the participants discussed, missing doses was attributed to being distracted, away from home, and timing issues. 
This is similar to the findings of a qualitative interview study of unintentional non-adherers taking medication 
for chronic  conditions30, which found schedule change, life pressures, and location change to be reasons for 
adherence failure, suggesting that work to improve adherence should focus on these routine-related factors. The 
theme of ‘change to routine’ is arguably not disease-specific but associated with medication taking in chronic 
illness more generally. Routine is rooted in physicality, related to time, space and occupation, which could all be 
manipulated through behaviour change therapies in order to remove practical and perceived barriers to taking 
 medicines31. However, this type of intervention might only be relevant where patients are unintentional non-
adherers, who aim to be good adherers (compared to others), rather than for intentional non-adherers who have 
no intention of taking medicines to start with.
A rich, detailed description of the lived experience of medication taking was achieved by the devotion of time, 
care and attention to the analysis. By using a case study approach, the results cannot claim to be exhaustive as 
there is no endpoint at data saturation as found in some qualitative methodologies. However, the use of com-
parison between cases has elicited superordinate themes for further investigation. In line with the ideographic 
nature of an IPA study, the results are not generalisable to larger populations but could be cautiously broadened 
to establish how they fit amongst different groups. IPA requires a homogeneity of sample with respect to the 
phenomena under investigation, and this was achieved through purposive selection of participants as all having 
experience of taking medication to prevent further AMI. This sample was similar due to their locality to the 
South-East of England, similar socio-economic profile and using UK NHS services to provide their healthcare. 
The results are not intended to be generalisable to other AMI populations outside of this specific context, but 
this is not the intention of IPA, instead finding universal patterns within specific detailed accounts drawn out 
by the analysis and thematic grouping work towards cautious claims of  transferability32.
An equal gender mix was observed, but results were not de-aggregated, contrary to SAGER  guidelines33. The 
rationale for this was the small participant number and ideography of an IPA methodology, where the focus 
is individual voice, and summary of detailed themes resonating through those voices, as opposed to a broader 
aggregation of themes.
The self-selection bias of participants may have affected the result of this study, as perhaps volunteers tend 
towards individuals with positive or more extreme experiences. The situational pressure of an interview may 
have contributed to the participants feeling obliged to satisfy the researcher’s line of questioning and present 
themselves in the best possible light, in the same way that a medical consultation might  do34. The method of 
analysis, IPA, is a close first-person study, and so the participant is interpreted as being truthful and without 
agenda. Future study to examine the performance and politics of the talk during the same interviews could be 
completed using discourse or conversation analysis as a more critical method.
The use of IPA fitted well with the research question and compliments the model of patient-centred care 
where empathy and understanding are valued. This study contributes to the discussion of methodology in 
phenomenological studies as the integration of existential categories was found to be useful in the organisation 
and analysis of the data. Other studies have found an integrated phenomenological approach to be beneficial to 
the production of their findings, such as using similar lifeworld  categories35,  enactivism36 and use of a revised 
grounded  methodology37.
This study has shown that whilst generalisations can be made, each patient’s experience is unique and the 
meaning they associate to their behaviour and action is very personal. Therefore, the case study approach to 
developing medicine-taking interventions is a valid one. This is congruent with NICE recommendations for 
medicine adherence support to be patient-centred with interventions adapted to  individuals12, and future work 
to be directed towards this area. This patient-centredness could be practised in pharmacy by way of motivational 
interviewing as an aid to medicine adherence, which in the UK is not currently a standard practice within the 
NHS.
Whilst fulfilling the aim of describing the medicine-taking experience, the relationship to medication adher-
ence, and more importantly, non-adherence is unclear. All the patients discussed rarely missing their doses, and 
so perhaps future studies could solely include the elusive volunteer group of non-adherent patients. This echoes 
the findings of the Cochrane review of adherence  interventions13, which concluded that more work ought to be 
completed with patients whose adherence is low.
Conclusion
This study found the meaning of medicine-taking in this participant group was oriented towards reducing 
the unknown and reinforcing stability and cohesion in their lives. This finding, alongside the themes that the 
analysis generated could help practitioners assisting patients in their medicine-taking experience. The theme of 
comparison to others was found to confer a moral superiority to the self and offers comfort against uncertainty. 
The theme of knowledge and looking towards the future contributed to a participant’s sense of coherence, again 
reducing anxiety of the unknown. Assimilation into lifestyle could be considered a modifiable learned behaviour, 
and medication routines could be strengthened by activity, location and timing interventions.
Meaning making was unique to individuals and so adherence interventions should be tailored to personal 
experiences in order to be more empathetic and therefore more impactful for an individual patient.
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The methodology highlighted the importance of considering the phenomena of adherence as part of the whole 
life of an individual, as it is the entirety of a patient’s world that imparts meaning to adherence. The ideographic 
approach of this study produced a rich dataset and aligns with a tailored intervention to improving adherence 
and with a patient-centred approach.
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